Advertisement
Canada markets open in 4 hours 57 minutes
  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     
  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • CAD/USD

    0.7291
    +0.0010 (+0.13%)
     
  • CRUDE OIL

    79.73
    +0.73 (+0.92%)
     
  • Bitcoin CAD

    79,467.07
    +1,395.73 (+1.79%)
     
  • CMC Crypto 200

    1,265.77
    -4.97 (-0.39%)
     
  • GOLD FUTURES

    2,316.80
    +5.80 (+0.25%)
     
  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     
  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     
  • NASDAQ futures

    17,590.50
    +152.25 (+0.87%)
     
  • VOLATILITY

    14.95
    -0.44 (-2.86%)
     
  • FTSE

    8,163.54
    +42.30 (+0.52%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6807
    +0.0014 (+0.21%)
     

Atlas Arteria Full Year 2023 Earnings: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria (ASX:ALX) Full Year 2023 Results

Key Financial Results

  • Revenue: AU$134.0m (down 4.5% from FY 2022).

  • Net income: AU$323.5m (up 21% from FY 2022).

  • EPS: AU$0.22.

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Atlas Arteria Earnings Insights

Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Infrastructure industry in Oceania.

Performance of the market in Australia.

The company's shares are down 2.5% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Atlas Arteria that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.